JACK HENRY & ASSOCIATES TO PROVIDE WEBCAST OF SECOND QUARTER 2025 EARNINGS CALL

Jack Henry & Associates, Inc.® (NASDAQ: JKHY) announced today that it will host a live Webcast of its second quarter 2025 earnings conference call on February 5, 2025. The press release announcing second quarter 2025 earnings will be issued after market close on February 4, 2025. https://mma.prnewswire.com/media/1868509/Jack_Henry_and_Associates_Logo.jpg The live webcast, which will begin at 7:45 […]

Ombud calls for fair treatment of Canadian Language and Cultural Advisors who served in Afghanistan

The Department of National Defence (DND) and Canadian Armed Forces (CAF) Ombud has released a report titled Standing together: Ensuring fair treatment for Canadian Language and Cultural Advisors who served in Afghanistan, a final call for the fair treatment of those who served alongside CAF members in Afghanistan. This report identified the multiple issues facing

BrushO Unveils AI-Powered Toothbrush at Stanford University, Redefining Oral Care

New York, NY, Jan. 22, 2025 (GLOBE NEWSWIRE) — BrushO, in partnership with Stanford School of Medicine, successfully hosted the launch event for the BrushO AI-Powered Toothbrush at the Stanford Faculty Club. This innovative AI oral care product, along with its unprecedented potential applications, was unveiled to a global audience, marking a pivotal moment in

Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline

(NasdaqGM:CDT), Award-winning Agility Life Sciences brings a proven track record in drug formulation for a number of pharmaceutical and biotechnology clients. NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 22, 2025 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company“), today announced that it has entered into a strategic services agreement with formulation

Viasat Announces Reorganization of Senior Executive Team

(NasdaqGM:VSAT), CARLSBAD, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) — Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced a restructuring of its Senior Executive Team to better position the company for long-term growth. Effective today, January 22, Craig Miller, currently President of Global Space Networks, will become Senior Vice President, Strategic Initiatives.

Infinidat Named to CRN’s Cloud 100 List for 2025

WALTHAM, Mass., Jan. 22, 2025 (GLOBE NEWSWIRE) — Infinidat, a leading provider of enterprise storage solutions, today announced that it has been named to the 2025 Cloud 100 list by CRN(R), a brand of The Channel Company. The company is recognized in the “Cloud Storage” category of this prestigious CRN list for Infinidat's hybrid multi-cloud

Palisade Bio to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar

(NASDAQ:PALI), Live webcast on Wednesday, January 29th at 2:20 PM ET Carlsbad, CA, Jan. 22, 2025 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that JD Finley, Chief

ZJK Industrial Co. Ltd. to Present at the 2025 Microcap Conference in Atlantic City

(NASDAQ:ZJK), Shenzhen, China, Jan. 22, 2025 (GLOBE NEWSWIRE) — ZJK Industrial Co. Ltd. (NASDAQ: ZJK) (“ZJK Industrial” or the “Company”), a high-tech precision parts and hardware manufacturer for artificial intelligence (AI) infrastructure and smart technologies, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The

Hepion Pharmaceuticals Announces $9.0 Million Public Offering

(NASDAQ:HEPA), EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, announced the launch of a “best efforts” public offering of 27,692,310 shares of common stock (or pre-funded warrants in

ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm

(NASDAQ:PRPH), Transaction Eliminates More Than $20 Million in Debt, and Other Financial Obligations, Provides $2 million in Cash and Significantly Enhances the Company's Balance Sheet and Liquidity The Company will review with shareholders at 2:00 p.m. EST, details below. GARDEN CITY, NY, Jan. 22, 2025 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or

Scroll to Top